Abstract
In patients with acute severe asthma, 5 mg of terbutaline by inhalation and 500 microgram intravenously in divided doses both produced equally effective but not maximal bronchodilatation. There was no difference in the production of side-effects. These results support the view that inhaled therapy can be as effective in patients with acute severe asthma as injected treatment. In view of the risks of intravenous treatment, especially using high doses, inhaled bronchodilator therapy would seem advisable as initial treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bloomfield P., Carmichael J., Petrie G. R., Jewell N. P., Crompton G. K. Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J. 1979 Mar 31;1(6167):848–850. doi: 10.1136/bmj.1.6167.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawford P., Jones B. J., Milledge J. S. Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J. 1978 Jan 14;1(6105):84–84. doi: 10.1136/bmj.1.6105.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams S. J., Parrish R. W., Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J. 1975 Dec 20;4(5998):685–685. doi: 10.1136/bmj.4.5998.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams S., Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. doi: 10.1136/thx.32.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]